Home » Authors » Trista Morrison

Articles by Trista Morrison

Aspreva Ends Speculation With $915M Acquisition

Oct. 19, 2007

By Trista Morrison

Aspreva Ends Speculation With $915M Acquisition

Oct. 19, 2007

By Trista Morrison

Cubist Gets Option To Acquire Illumigen; Funds HCV Drug

Oct. 18, 2007

By Trista Morrison

Cubist Pharmaceuticals Inc. moved to expand its pipeline beyond Cubicin (daptomycin for injection) by picking up an exclusive option to acquire Illumigen Biosciences Inc. (BioWorld Today)

Cubist Gets Option To Acquire Illumigen; Funds HCV Drug

Oct. 18, 2007

By Trista Morrison

Cubist Pharmaceuticals Inc. moved to expand its pipeline beyond Cubicin (daptomycin for injection) by picking up an exclusive option to acquire Illumigen Biosciences Inc. (BioWorld Today)

Cytokinetics Gets $75M Option; Aastrom Raises $13.5M Publicly

Oct. 17, 2007

By Trista Morrison

Cytokinetics Gets $75M Option; Aastrom Raises $13.5M Publicly

Oct. 17, 2007

By Trista Morrison

Memory Falls As MEM 1003 Misses In Phase IIa AD Trial

Oct. 16, 2007

By Trista Morrison

Memory Falls As MEM 1003 Misses In Phase IIa AD Trial

Oct. 16, 2007

By Trista Morrison

NewCo News: Meditrina Teaches Cancer Fighter New Tricks In Women's Health

Oct. 15, 2007

By Trista Morrison

NewCo News: Meditrina Teaches Cancer Fighter New Tricks In Women's Health

Oct. 15, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...